华邦健康(002004) - 2020 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2020 was ¥2,254,687,980.04, representing a decrease of 8.09% compared to ¥2,453,145,195.80 in the same period last year[9] - Net profit attributable to shareholders was ¥82,868,734.68, down 17.15% from ¥100,028,288.20 year-over-year[9] - The net profit after deducting non-recurring gains and losses was ¥78,033,653.00, a decrease of 13.69% compared to ¥90,409,946.85 in the previous year[9] - Basic and diluted earnings per share were both ¥0.04, down 20.00% from ¥0.05 in the previous year[9] - Net profit for Q1 2020 was CNY 100,386,554.23, down 32.8% from CNY 149,314,508.71 in the same period last year[57] - Total comprehensive income for Q1 2020 was CNY 121,333,970.77, compared to CNY 135,939,588.96 in the previous period[60] - The net profit for the current period is 210,287,845.91, compared to a net loss of 31,617,729.63 in the previous period, indicating a significant turnaround[64] - The total comprehensive income for the current period is 210,287,845.91, while the previous period recorded a total comprehensive loss of 31,617,729.63[67] - Basic and diluted earnings per share for the current period are both 0.11, compared to -0.02 in the previous period, reflecting improved profitability[67] Cash Flow - The net cash flow from operating activities increased by 42.35% to ¥179,982,272.78 from ¥126,435,744.62 in the same period last year[9] - Cash flow from operating activities generated a net amount of 179,982,272.78, an increase from 126,435,744.62 in the previous period[71] - Net cash flow from operating activities was $947,322.07, a significant improvement from a net outflow of $1,221,888.16 in the previous period[76] - Cash inflow from investment activities totaled 2,600,016,722.22, compared to 1,917,745,330.79 in the previous period, showing a strong increase in investment returns[73] - Cash outflow from investment activities was 2,998,462,472.54, up from 2,094,936,077.19 in the previous period, indicating increased investment activity[73] - Cash flow from financing activities generated a net amount of 551,649,767.85, compared to 471,809,739.79 in the previous period, reflecting improved financing conditions[73] Assets and Liabilities - Total assets at the end of the reporting period were ¥28,560,817,306.87, an increase of 7.22% from ¥26,636,399,413.94 at the end of the previous year[9] - Total liabilities reached ¥14,948,977,448.61, up from ¥13,392,665,230.51, marking a growth of around 11.6%[41] - Current liabilities rose to ¥12,343,706,521.22 from ¥10,960,277,159.35, reflecting an increase of approximately 12.5%[41] - Total liabilities increased to CNY 7,565,367,559.86 from CNY 6,260,770,065.78, representing a rise of approximately 20.8%[49] - The company's total current assets rose to RMB 11,854,815,825.86, up from RMB 10,058,818,575.50, indicating a growth of 17.83%[35] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 99,964[15] - The largest shareholder, Tibet Huibang Technology Co., Ltd., held 18.71% of the shares, with a total of 370,449,804 shares[15] - Total equity attributable to shareholders increased to ¥9,555,749,481.92 from ¥9,340,773,415.18, reflecting a growth of about 2.3%[44] Expenses - Total operating costs decreased to CNY 2,144,965,786.61 from CNY 2,320,052,157.98, reflecting a reduction of about 7.5%[54] - Research and development expenses increased to CNY 75,496,146.72 from CNY 67,609,739.77, marking an increase of approximately 11.1%[54] - Financial expenses decreased significantly to CNY 100,416,512.59 from CNY 175,981,757.06, a reduction of about 43%[54] Investment Activities - The company reported a total of RMB 149,463.73 million in entrusted financial management, with no overdue amounts[27] - The company reported investment income of CNY 26,782,061.58, down from CNY 42,665,426.83 in the previous period[54] - Cash received from investment returns was $58,447,955.38, compared to $36,197,721.06 in the previous period, representing a growth of about 61.5%[76]